Saturday, July 11, 2026

biotech · Esophageal Squamous Cell Carcinoma

Jiangsu Alphamab Biopharmaceuticals

News and analysis for Jiangsu Alphamab Biopharmaceuticals on NovaPharmaNews — regulatory, clinical, and market coverage.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Jiangsu Alphamab Biopharmaceuticals — regulatory, clinical, and market coverage.

News and analysis for Jiangsu Alphamab Biopharmaceuticals on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Jiangsu Alphamab Biopharmaceuticals yet.

Back to company overview →